Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial
Jeffrey I. Zwicker(Memorial Sloan Kettering Cancer Center), Alok A. Khorana(Cleveland Clinic), Mäneka Puligandla(Dana-Farber Cancer Institute), Benjamin L. Schlechter(Brigham and Women's Hospital), Joanna Roopkumar(Mayo Clinic in Florida), Bruno Bockorny(Harvard University), David M. Peereboom(Texas Tech University), Anish V. Sharda(Beth Israel Deaconess Medical Center), Donna Neuberg(Otsuka (Japan)), Kenneth A. Bauer(VA Boston Healthcare System), Robin Joyce(Beth Israel Deaconess Medical Center)
Cited by 31